LYNN VINCENT: Open Payments
NPI 1023249497 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 31 payments from 10 companies in 2025. Trend: 2023 $876 · 2024 $3,337 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $327 |
| Philips North America LLC | 1 | $145 |
| E.R. Squibb & Sons, L.L.C. | 1 | $128 |
| Medtronic, Inc. | 1 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| Boston Scientific Corporation | 1 | $14 |
| Amgen Inc. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, LM Undivided, CAMZYOS, SYMPLICITY G3, ENTRESTO, Kerendia, VYNDAQEL, WATCHMAN Access System.
Industry payments across MS — which companies pay providers there.
